ADT1153-Crovalimab Biosimilar-Anti-C5 mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1153 |
Product Name |
ADT1153-Crovalimab Biosimilar-Anti-C5 mAb-Research Grade |
|
Alternate Names anti-c5 monoclonal antibody, c5 antibody, anti c5 antibody, c5 monoclonal antibody, anti-Complement 5 antibody, anti Complement 5 antibody, recombinant c5, c5 antibodies, c5 recombinant antibody, c5 blocking antibody |
|
Alias |
RG-6107, RO7112689, SKY-59 |
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Human |
Target |
C5 |
Gene ID |
727 |
Isotype |
IgG1 Kappa |
Size |
100ug, 1mg, 5mg |
Research Area |
Immunology |
CAS Number |
1917321-26-6 |
Product Description |
Crovalimab is under investigation in clinical trial NCT03157635 (Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria). |
Application |
ELISA, WB |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
|
Reference 1. Kowalska D, et al. Front Immunol, 2022. PMID 36091057
2. Mateu-Borrás M, et al. Virulence, 2022 Dec. PMID 35094639
3. Skjeflo EW, et al. Blood, 2021 Nov 25. PMID 34339498
|





